Compare VTS & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VTS | CTKB |
|---|---|---|
| Founded | 2014 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 756.5M | 652.1M |
| IPO Year | 2022 | 2021 |
| Metric | VTS | CTKB |
|---|---|---|
| Price | $18.68 | $4.54 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 5 |
| Target Price | ★ $26.50 | $5.70 |
| AVG Volume (30 Days) | 473.0K | ★ 706.8K |
| Earning Date | 03-02-2026 | 05-07-2026 |
| Dividend Yield | ★ 11.84% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.64 | N/A |
| Revenue | ★ $273,989,000.00 | $193,015,000.00 |
| Revenue This Year | $1.81 | $5.42 |
| Revenue Next Year | N/A | $7.03 |
| P/E Ratio | $29.61 | ★ N/A |
| Revenue Growth | 13.22 | ★ 17.67 |
| 52 Week Low | $17.44 | $2.37 |
| 52 Week High | $27.15 | $6.18 |
| Indicator | VTS | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 39.73 | 55.97 |
| Support Level | $17.44 | $4.56 |
| Resistance Level | $20.17 | $5.24 |
| Average True Range (ATR) | 0.52 | 0.18 |
| MACD | -0.05 | 0.07 |
| Stochastic Oscillator | 15.03 | 80.00 |
Vitesse Energy Inc is an independent energy company focused on returning capital to stockholders through owning interests as a non-operator in oil and natural gas wells. It is engaged in the acquisition, development, and production of non-operated oil and natural gas properties in the United States that are generally operated by oil companies and are in the Williston Basin of North Dakota and Montana. The company also have properties in the Central Rockies, including the Denver-Julesburg Basin and the Powder River Basin.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.